IP Library Assignment 059025/0876
Patent Assignment
Reel/Frame 059025/0876

Assignment of Assignor's Interest

Recorded: 2022-02-16 Pages: 5
Assignors
DUBE, SUSHANT OMPRAKASH
Executed: 2021-04-12
KULKARNI, PURUSHOTTAM DATTATRAYA
Executed: 2021-04-12
PATTEWAR, PURUSHOTTAM SAKHAHARI
Executed: 2021-04-12
PILLAI, SUMITRA ASHOKKUMAR
Executed: 2021-04-12
Assignee
SLAYBACK PHARMA LLC
301 CARNEGIE CENTER, SUITE 303, PRINCETON, NEW JERSEY, 08540
Covered Property (1)
Pharmaceutical Compositions of Tofacitinib for Oral Administration
Application: 17/239,007 →
Publication: US 2021/0338677
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest Sep 27, 2023
From: SLAYBACK PHARMA LIMITED LIABILITY COMPANY
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065045/0560 →
Partial Termination and Release of Security Interest in Patents Apr 3, 2024
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: SLAYBACK PHARMA LIMITED LIABILITY COMPANY
Reel/Frame 066987/0120 →
Assignment of Assignor's Interest Apr 19, 2024
From: SLAYBACK PHARMA LIMITED LIABILITY COMPANY
To: HIKMA PHARMACEUTICALS USA INC.
Reel/Frame 067168/0238 →
Release of Security Interest Mar 14, 2025
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: AZURITY PHARMACEUTICALS, INC.; SILVERGATE PHARMACEUTICALS, INC.; ARBOR PHARMACEUTICALS, LLC; SLAYBACK PHARMA LIMITED LIABILITY COMPANY
Reel/Frame 070521/0299 →